For the genotyping of over one million potential stem cell donors per year, we developed a highly automated workflow with the largest genotyping profile worldwide. Thus, we do not only report mandatory genes but also genes, whose relevance is still an ongoing discussion in the scientific community.
By providing pre-genotyped donors for these genes, we facilitate further studies, which will hopefully lead to an improved donor selection in the future.
For patients and related samples, we are applying a workflow providing ultra-high-resolution HLA genotyping. Here, we analyze not only exons 2 and 3 of the HLA genes but the whole gene (HLA class I) or at least exons 2 to 5 (HLA class II).
For urgent genotyping requests, we are offering rSSO (Luminex) based HLA genotyping enabling next-day results. rSSO technology is based on PCR amplification with biotinylated HLA allele group-specific primers.
2026 Jan 01
2026 Apr 03
2026 Apr 06
2026 May 01
2026 May 14
2026 May 25
2026 Oct 03
2026 Oct 31
2026 Nov 18
2026 Dec 25
2026 Dec 26
